The pharmacology of the cytochrome P450 enzyme system

Bailliere's Clinical Anaesthesiology

Volumn 12, Issue 2, 1998, Pages 191-211

  Kitteringham, N R ^a   Pirmohamed, M ^a   Park, B K ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

CYP; Cytochrome P450; Drug response; Drug toxicity; Idiosyncratic toxicity; Interindividual variation

Indexed keywords

CYTOCHROME P450; OXYGEN;

COMPETITION; DRUG INTERACTION; DRUG METABOLISM; ENZYME INHIBITION; ENZYME SPECIFICITY; GENETIC POLYMORPHISM; LIVER METABOLISM; METABOLISM; MULTIGENE FAMILY; PRIORITY JOURNAL; PROTEIN FAMILY; REVIEW;

EID: 0031660126     PISSN: 09503501     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0950-3501(98)80028-7     Document Type: Article

References (98)

1. Alvares AP Schiling G Levin W Kuntzman R Studies on the induction of CO-binding pigments in liver microsomes by phenobarbital and 3-methylcholanthrene Biochemical and Biophysical Research Communications 29 1967 531
2. Armstrong M Fairbrother K Idle Jr Daly AK The cytochrome P450 CYP2D6 allelic variant CYP2D6J and related polymorphisms in a European population Pharmacogenetics 4 1994 73 81
3. Back DJ Orme ML'E Drug interactions Goldzieher JW Pharmacology of the Contraceptive Steroids 1994 Raven Press New York 407 425
4. Bailey DG Arnold JMO Spence JD Grapefruit juice and drugs: how significant is the interaction? Clinical Pharmacokinetics 26 1994 91 98
5. Berdeaux A Nitric-oxide—an ubiquitous messenger Fundamental Clinical Pharmacology 7 1993 401 411
6. Bertz RJ Granneman GR Use of in vitro and in vivo data to estimate the likelihood of metabolic pharmacokinetic interactions Clinical Pharmacokinetics 32 1997 210 258
7. Bray GP Liver failure induced by paracetamol British Medical Journal 306 1993 157 158
8. Bray GP Harrison PM O'Grady JG Long-term anticonvulsant therapy worsens outcome in paracetamol-induced fulminant hepatic-failure Human and Experimental Toxicology 11 1992 265 270
9. Brosen K Gram LF Clinical significance of the sparteine-debrisoquine oxidation polymorphism European Journal of Clinical Pharmacology 36 1989 537 547
10. Cholerton S Daly AK Idle JR The role of individual human cytochromes P450 in drug metabolism and clinical response Trends in Pharmacological Science 13 1992 434 439
11. Cohen EN Trudell JR Edmunds HN Watson E Urinary metabolites of halothane in man Anesthesiology 43 1975 392 401
12. Daly AK Molecular basis of polymorphic drug metabolism Journal of Molecular Medicine 73 1995 539 553
13. Degtyarenko KN Structural domains of P450-containing monooxygenase systems Protein Engineering 8 1995 737 747
14. Eger EI Smuckler EA Ferrell LD Is enflurane hepatotoxic? Anesthesia and Analgesia 65 1986 21 30
15. Eichelbaum M Gross AS The genetic polymorphism of debrisoquine/sparteine metabolism—clinical aspects Pharmacology and Therapeutics 46 1990 377 394
16. Endres S Cannon JG Ghorbani R In vitro production of IL-1-beta, IL-1-alpha, TNF and IL-2 in healthy-subjects—distribution, effect of cyclooxygenase inhibition and evidence of independent gene regulation European Journal of Immunology 19 1989 2327 2333
17. Fernandez-Salguero P Gonzalez FJ The CYP2A gene subfamily—species differences, regulation, catalytic activities and role in chemical carcinogenesis Pharmacogenetics 5 1995 S123 S128
18. Fernandez-Salguero P Hoffman SMG Cholerton S A genetic polymorphism in coumarin 7-hydroxylation—sequence of the human CYP2A genes and identification of variant CYP2A6 alleles American Journal of Human Genetics 57 1995 651 660
19. First MR Schroeder TJ Alexander JW Cyclosporine dose reduction by ketoconazole administration in renal transplant recipients Transplantation 51 1991 365 370
20. Frink EJ The hepatic effects of sevoflurane Anesthesia and Analgesia 81 1995 S46 S50
21. Furuya H Fernandez-Salguero P Gregory W Genetic polymorphism of CYP2C9 and its effect on warfarin maintenance dose requirement in patients undergoing anticoagulation therapy Pharmacogenetics 5 1995 389 392
22. Goldstein JA de Morais SMF Biochemistry and molecular biology of the human CYP2C subfamily Pharmacogenetics 4 1994 285 300
23. Goldstein JA Faletto MB Romkes-Sparks M Evidence that CYP2C19 is the major (s)-mephenytoin 4′-hydroxylase in humans Biochemistry 33 1994 1743 1752
24. Gonzalez FJ The molecular biology of cytochrome P450s Pharmacological Reviews 40 1989 243 288
25. Gonzalez FJ Human cytochromes P450: problems and prospects Trends in Pharmacological Sciences 13 1992 346 352
26. Gonzalez FJ Gelboin HV Role of human cytochromes P450 in the metabolic activation of chemical carcinogens and toxins Drug Metabolism Reviews 26 1994 165 183
27. Gonzalez F Meyer UA Molecular genetics of the debrisoquin-sparteine polymorphism Clinical Pharmacology and Therapeutics 50 1991 233 238
28. Gonzalez FJ Liu SY Yano M Regulation of cytochrome P-450 genes: molecular mechanisms Pharmacogenetics 3 1993 51 57
29. Guengerich FP Characterization of human cytochrome P450 enzymes FASEB Journal 6 1992 745 748
30. Guengerich FP Metabolic activation of carcinogens Pharmacology and Therapeutics 54 1992 17 61
31. Gut J Christen U Huwyler J Mechanisms of halothane toxicity: novel insights Pharmacology and Therapeutics 58 1993 133 155
32. (Tokyo) Hayashi S Watanabe J Kawajiri K Genetic polymorphisms in the 5′-flanking region change transcriptional regulation of the human cytochrome P450IIE1 gene Journal of Biochemistry 110 1991 559 565
33. Horowitz JD White HD Goble AJ Liver-disease induced by perhexilene maleate Medical Journal of Australia 2 1982 9 10
34. Ilyin GP Rissel M Malledant Y Human hepatocytes express trifluoroacetylated neoantigens after in vitro exposure to halothane Biochemical Pharmacology 48 1994 561 567
35. Imai Y Sato R Evidence for two forms of P-450 hemoprotein in microsomal membranes Biochemical and Biophysical Research Communications 23 1966 5
36. Ingelman-Sundberg M Johansson I Yin H Ethanol-inducible cytochrome P4502E1—genetic polymorphism, regulation, and possible role in the etiology of alcohol-induced liverdisease Alcohol 10 1993 447 452
37. Johansson I Lundqvist E Bertilsson L Inherited amplification of an active gene in the cytochrome-P450 CYP2D locus as a cause of ultrarapid metabolism of debrisoquine Proceedings of the National Academy of Sciences of the USA 90 1993 11825 11829
38. Karashima D Hirokata Y Shigematsu A Furakawa T The in vitro metabolism of halothane (2-bromo-2-chloro-1,1,1-trifluoroethane) by hepatic microsomal cytochrome P-450 Journal of Pharmacology and Experimental Therapeutics 203 1977 409 416
39. Kawajiri K Watanabe J Eguchi H Hayashi S Genetic polymorphisms of drug-metabolizing-enzymes and lung-cancer susceptibility Pharmacogenetics 5 1995 S70 S73
40. Kellermann G Luyten-Kellermann M Shaw CR Genetic variation of aryl hydrocarbon hydroxylase in human lymphocytes American Journal of Human Genetics 25 1973 327 331
41. Kenna JG Satoh H Christ DD Pohl LR Metabolic basis for a drug hypersensitivity: antibodies in sera from patients with halothane hepatitis recognize liver neoantigens that contain the trifluoroacetyl group derived from halothane Journal of Pharmacology and Experimental Therapeutics 245 1988 1103 1109
42. Kharasch ED Thummel KE Identification of cytochrome P450 2E1 as the predominant enzyme catalysing human liver microsomal defluorination of sevoflurane, isoflurane and methoxyflurane Anesthesiology 79 1993 795 807
43. Kharasch ED Hankins DC Thummel KE Human kidney methoxyflurane and sevoflurane metabolism. Intrarenal fluoride production as a possible mechanism of methoxyflurane nephrotoxicity Anesthesiology 82 1995 689 699
44. Kharasch ED Hankins D Mautz D Thummel KE Identification of the enzyme responsible for oxidative halothane metabolism—implications for prevention of halothane hepatitis Lancet 347 1996 1367 1371
45. Klingenberg M Pigments of rat liver microsomes Archives of Biochemistry and Biophysics 75 1958 375 386
46. Koymans LMH Vermeulen NPE Baarslag A Donne-Op den Kelder GM A preliminary 3D model for cytochrome P450 2D6 constructed by homology model building Journal of Computer-Aided Molecular Design 7 1993 281 289
47. Kumar GN Rodrigues AD Buko AM Denissen JF Cytochrome P450-mediated metabolism of the HIV-1 protease inhibitor ritonavir (ABT-538) in human liver microsomes Journal of Pharmacology and Experimental Therapeutics 277 1996 423 431
48. LaBella FS Chen Q-M Stein D Queen G The site of general anesthesia and cytochrome P450 oxygenases: similarities defined by straight chain and cyclic alcohols British Journal of Pharmacology 120 1997 1158 1164
49. McKinnon RA Hall PD Quattrochi LC Localization of cypla1 and cypla2 messenger-RNA in normal human liver and in hepatocellular-carcinoma by in situ hybridization Hepatology 14 1991 848 856
50. Makita K Falck JR Capdevila JH Cytochrome P450, the arachidonic acid cascade, and hypertension: new vistas for an old enzyme system FASEB Journal 10 1996 1456 1463
51. Manns MP Cytochrome P450 enzymes as human autoantigens Immunological Research 10 1991 503 507
52. Mazze RI Cousins MJ Renal toxicity of anaesthetics: with specific reference to the nephrotoxicity of methoxyflurane Canadian Anesthetists Society Journal 20 1973 64 80
53. Mazze RI Cousins MJ Barr GA Renal effects and metabolism of isoflurane in man Anesthesiology 40 1974 536 542
54. Mazze RI Calverley RK Smith NT Inorganic fluoride nephrotoxicity: prolonged enflurane and halothane anaesthesia in volunteers Anesthesiology 46 1977 265 271
55. Merry C Mulcahy F Barry M Saquinavir interaction with midazolam: pharmacokinetic considerations when prescribing protease inhibitors for patients with HIV disease AIDS 11 1997 268 269
56. Molvig J Baek L Christensen P Endotoxin-stimulated human monocyte secretion of interleukin-1, tumor necrosis factor-alpha, and prostaglandin-e2 shows stable interindividual differences Scandinavian Journal of Immunology 27 1988 705 716
57. Morgan MY Reshef R Shah RR Impaired oxidation of debrisoquine in patients with perhexilene liver injury Gut 10 1984 1057 1064
58. National Halothane Study Summary of the national halothane study Journal of the American Medical Association 197 1966 121 134
59. Nebert DW McKinnon RA Cytochrome P450: evolution and functional diversity Progress in Liver Disease 12 1994 63 97
60. Nebert DW Adesnik M Coon MJ The P450 gene superfamily. Recommended nomenclature DNA 6 1987 1 11
61. Nebert DW Nelson DR Adesnik M The P450 gene superfamily. Update on the naming of new genes and nomenclature of chromosomal loci DNA 8 1989 1 13
62. Nebert DW Nelson DR Coon MJ The P450 superfamily: update on new sequences, gene mapping, and recommended nomenclature DNA and Cell Biology 10 1991 1 14
63. Nebert DW Puga A Vasiliou V Role of the ah receptor and the dioxin-inducible [ah]gene battery in toxicity, cancer, and signal-transduction Annals of the New York Academy of Sciences 685 1993 624 640
64. Nelson DR Kamataki T Waxman DJ The P450 superfamily—update on new sequences, gene-mapping, accession numbers, early trivial names of enzymes, and nomenclature DNA and Cell Biology 12 1993 1 51
65. Nelson DR Koymans L Kamataki T P450 superfamily: update of new sequences, gene mapping, accession numbers and nomenclature Pharmacogenetics 6 1996 1 42
66. Omura T Sato R The carbon monoxide binding pigment of liver microsomes Journal of Biological Chemistry 239 1964 2370 2378
67. Park BK Metabolic basis of adverse drug reactions Journal of the Royal College of Physicians 20 1986 195 200
68. Park BK Kitteringham NR Effects of fluorine substitution on drug-metabolism—pharmacological and toxicological implications Drug Metabolism Reviews 26 1994 605 643
69. Park BK Pirmohamed M Kitteringham NR Idiosyncratic drug reactions: a mechanistic evaluation of risk factors British Journal of Clinical Pharmacology 34 1992 377 395
70. Park BK Kitteringham NR Pirmohamed M Tucker GT Relevance of induction of human drug-metabolizing enzymes: pharmacological and toxicological implications British Journal of Clinical Pharmacology 41 1996 477 491
71. Pessayre D Larrey D Acute and chronic drug-induced hepatitis Baillière's Clinical Gastroenterology 2 1988 385 423
72. Pirmohamed M Park BK Enzyme inhibition-mediated toxic effects of drugs Sandler M Smith J Design of Enzyme Inhibitors as Drugs 1994 OUP Oxford 800 818
73. Pirmohamed M Kitteringham NR Park BK The role of active metabolites in drug toxicity Drug Safety 11 1994 114 144
74. Pirmohamed M Williams D Madden S Metabolism and bioactivation of clozapine by human liver in vitro Journal of Pharmacology and Experimental Therapeutics 272 1995 984 990
75. Pirmohamed M Madden S Park BK Idiosyncratic drug reactions: metabolic bioactivation as a pathogenic mechanism Clinical Pharmacokinetics 31 1996 215 230
76. Porter TD Coon MJ Cytochrome P-450 Journal of Biological Chemistry 266 1991 13 469 13 472
77. Prough RA Introduction: basal and inducible expression of cytochromes P450 and related enzymes FASEB Journal 10 1996 807 808
78. Raucy JL Risk assessment—toxicity from chemical-exposure resulting from enhanced expression of cyp2e1 Toxicology 105 1995 217 224
79. Rehder K Forbes J Alter H Halothane biotransformation in man: a quantitative study Anesthesiology 28 1967 711 715
80. Roman RJ Carter JR North WC Kauker ML Renal tubular site of action of fluoride in Fischer 344 rats Anesthesiology 46 1977 260 264
81. Shah RR Oates NS Idle JR Impaired oxidation of debrisoquine in patients with perhexilene neuropathy British Medical Journal 284 1982 295 298
82. Smith CAD Gough AC Leigh PN Debrisoquine hydroxylation gene polymorphism and susceptibility to Parkinson's disease Lancet i 1992 1375 1377
83. Smith CAD Smith G Wolf CR Genetic polymorphisms in xenobiotic metabolism European Journal of Cancer 30A 1994 1921 1935
84. Spina E Pollicino AM Avenoso A Fluvoxamine-induced alterations in plasma concentrations of imipramine and desipramine in depressed patients International Journal of Clinical Pharmacology Research 13 1993 167 171
85. Stevens JC Wrighton SA Interaction of the enantiomers of fluoxetine and norfluoxetine with human liver cytochromes—P450 Journal of Pharmacology and Experimental Therapeutics 266 1993 964 971
86. Tephly TR Burchell B UDP-glucuronyl transferases: a family of detoxifying enzymes Trends in Pharmacological Sciences 11 1990 276 279
87. Tjia JF Colbert J Back DJ Theophylline metabolism in human liver-microsomes—inhibition studies Journal of Pharmacology and Experimental Therapeutics 276 1996 912 917
88. Tsutsumi M Lasker JM Shimizu M The intralobular distribution of ethanol-inducible-P450iie1 in rat and human-liver Hepatology 10 1989 437 446
89. Tyndale RF Sunahara T Inaba T Neuronal cytochrome P450IID1 (debrisoquine/sparteine-type): potent inhibition of activity by (−)-cocaine and nucleotide sequence identity to human hepatic P450 gene CYP2D6 Molecular Pharmacology 40 1991 63 68
90. Vergani D Mieli-Vergani G Type II autoimmune hepatitis. What is the role of the hepatitis C virus? Gastroenterology 104 1993 1870 1873
91. Vermeulen NPE Role of metabolism in chemical toxicity Ioannides C Cytochromes P450: Metabolic and Toxicological Aspects 1996 CRC Press Boca Raton 29 54
92. Wang Y Marsden PA Nitric oxide synthases: biochemical and molecular regulation Current Opinion in Nephrology and Hypertension 4 1995 12 22
93. Waxman DJ Azaroff L Phenobarbital induction of cytochrome P-450 gene expression Biochemical Journal 281 1992 577 592
94. Whitlock JP Mechanistic aspects of dioxin action Chemical Research in Toxicology 6 1993 754 763
95. Williams RT The metabolism of drugs and toxic substances Annual Review of Biochemistry 20 1951 441 464
96. Wolf CR Smith CAD Forman D Metabolic polymorphisms in carcinogen metabolising enzymes and cancer susceptibility British Medical Bulletin 50 1994 718 731
97. Yin HQ Anders MW Korzekwa KR Designing safer chemicals—predicting the rates of metabolism of halogenated alkanes Proceedings of the National Academy of Sciences of the USA 92 1995 11 076 11 080
98. Zimmerman HJ Maddrey WC Acetaminophen (paracetamol) hepatotoxicity with regular intake of alcohol: analysis of instances of therapeutic misadventure Hepatology 22 1995 767 773